premières réunions européennes sur les investissements et partenariats stratégiques dans les technologies médicales débutantes
NEWPORT BEACH, Californie -- (BUSINESS WIRE) -- May 26, 2005 –
Bruxelles, Belgique 20 et 21 septembre 2005
Medtech Insight a annoncé que Stefan Widensohler, Président Directeur général de KRAUTH Medical Group, ferait une présentation à l'occasion de la conférence « Investment In Innovation (In3) EUROPE: A Preview of Early-Stage Medical Technology Companies » (« Investir dans l'innovation (In3 EUROPE) : panorama des sociétés de technologie médicale débutantes »), qui se tiendra à Bruxelles, en Belgique, les 20 et 21 septembre prochain.
(BW)(CA-MEDTECH-INSIGHT) Medtech Insight's In3 EUROPE Early-Stage Medical Technology Investment and Partnering Conference to Feature Presentation by Stefan Widensohler, President and CEO of KRAUTH Medical Group
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--May 26, 2005—
Brussels, Belgium September 20-21, 2005
Medtech Insight has announced that Stefan Widensohler, president and CEO of KRAUTH Medical Group, will present at their upcoming "Investment In Innovation (In3) EUROPE: A Preview of Early-Stage Medical Technology Companies" conference in Brussels, Belgium, Sept.20 and 21, 2005. Widensohler has been active in the European healthcare community for a number of years and currently serves as deputy chairman of the board of BV-Med, the German Health Industry Manufacturers' Association and is an active member of the German Economic Council. He presently is president and CEO of KRAUTH Medical Group, a leading European medical supply distributor primarily serving the German healthcare market.
He also serves as a member of the board of directors of St. Jude Medical and Orthofix International N.V. Previously, he was general manager of MEDICALIS, now a GE Company, focusing on turn-key-project-management of hospital departments with special focus on the operating room area.
Widensohler is an economics graduate from the Private Academy of Bad Harzburg, Germany. In3 EUROPE, Medtech Insight's first European "Investment In Innovation" medical technology strategic partnering and investment event, is being held at The Crowne Plaza Brussels City Centre Hotel and will bring together 50 emerging medical technology companies from around the world seeking funding, acquisition and/or strategic partnership, with major medical technology and investment dealmakers (regularly updated details will be posted at http://www.medtechinsight.com/in3-europe-01.html).
The company's past U
.S. "Investment In Innovation" conferences have hosted nearly 550 early-stage medical companies, making it one of the most successful networking and partnering events in the medical device industry. For more information or to register to attend or present at the In3 EUROPE event, contact Scott Pantel of Medtech Insight at 949-219-0150, or 888-290-2225 in the U.S., e-mail [email protected], or visit the Medtech Insight Web site at http://www.medtechinsight.com/in3-europe-01.html.
Through May 31 only, attendees registering for the conference can save USD500 off the USD1,495 registration fee. Now a division of Windhover Information Inc., Medtech Insight is the leading provider of business information and market intelligence for the medical technology marketplace.
For more on the company's products and services, please see www.medtechinsight.com.
CONTACT: Medtech Insight, Newport Beach
Scott Pantel, 949-219-0150 888-290-2225 (toll-free in the U.S.) [email protected] www.medtechinsight.com www.windhover.com
KEYWORD: CALIFORNIA BELGIUM INTERNATIONAL EUROPE TRACK
INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL MEDICAL DEVICES BIOTECHNOLOGY BANKING TRADESHOW
SOURCE: Medtech Insight